Search results
Results From The WOW.Com Content Network
The Vaccine Research Center (VRC), is an intramural division of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), US Department of Health and Human Services (HHS). The mission of the VRC is to discover and develop both vaccines and antibody-based products that target infectious ...
The National Institute of Allergy and Infectious Diseases (NIAID, / ˈ n aɪ. æ d /) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS).
Matthew J. Memoli is an American physician-scientist and infectious disease researcher serving as the acting director of the National Institutes of Health (NIH) since 2025. He was the director of the Laboratory of Infectious Diseases (LID) Clinical Studies Unit in the National Institute of Allergy and Infectious Diseases (NIAID).
The National Institutes of Health, Islamabad (NIH) (Urdu: قومی ادارہَ صحت), is a Pakistani research institute located in Islamabad, Pakistan.. The institute is an autonomous body of Ministry of National Health Services, Regulation and Coordination, mainly responsible for biomedical and health related research along with vaccine manufacturing.
This comprehensive vaccine and prevention program has led to a number of significant scientific advances in vaccine and prevention research. In the past, NIAID supported researchers have improved antigenicity through modifications to the envelope protein, elucidated the envelope structure of HIV, advanced our understanding of the role of ...
He was the director of the Vaccine Research Center [1] (VRC), part of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). He also served as a principal advisor to Anthony Fauci, director of NIAID, on vaccines and biomedical research affairs. Mascola is the current Chief Scientific Officer for ...
Graham's research found that some virus proteins change shape after they break into a person's cells, leading to the design of a better vaccine against respiratory syncytial virus. [ 14 ] [ 15 ] In 2021 he received the Albany Medical Center Prize , [ 16 ] and in 2022 he was awarded the John J. Carty Award for the Advancement of Science of the ...
McLellan, along with Barney S. Graham and Peter Kwong of the National Institute of Allergy and Infectious Diseases' Vaccine Research Center, spearheaded the development of a protein subunit vaccine against RSV called DS-Cav1. [33] When the work began, McLellan was a postdoctoral researcher at VRC working in Graham's and Kwong's labs.